“Folks on this board…them…they deserve this”. Sounds like you are out? If so, very sorry to hear that - you have been a valued source of clarity regarding this stock. Happy holidays, llama.
www.ncbi.nlm.nih.gov › pmc › articlesVirosome-based nanovaccines; a promising bioinspiration and ... Jul 01, 2021 · Especial efforts should be put on virosome-based viral vaccine improvements and further tests to accelerate the approval process. Transvac 2 is a new virosomal vaccine designed against sarscov2 viruses that are in phase ?? clinical trials.The transvac 2 vaccine is an innovative compound expected to be helpful in the recent viral pandemic.